Trials / Completed

CompletedNCT04224896

Narrow-Band Imaging (NBI) Versus Lugol Chromoendoscopy in the Detection of Oesophagus Squamous Cell Carcinoma in High Risk Population

Narrow-Band Imaging (NBI) Versus Lugol Chromoendoscopy in the Detection of Oesophagus Squamous Cell Carcinoma in High Risk Population: a Randomised Controlled Multicentre Trial

Status: Completed
Phase: —
Study type: Observational
Enrollment: 335 (actual)

Sponsor: Hôpital Edouard Herriot · Academic / Other
Sex: All
Age: 18 Years – 80 Years
Healthy volunteers: Accepted

Summary

Narrow-Band Imaging (NBI) is as sensitive as Lugol chromoendoscopy to detect oesophageal squamous cell carcinoma (SCC) and appears more specific than Lugol chromoendoscopy in expert centres but its specificity in current practice is not known. This study aimed to prove the superiority of NBI specificity over Lugol chromoendoscopy to detect oesophageal SCC and high-grade dysplasia (HGD) in current practice (including tertiary care centres, local hospitals and private clinics).

Conditions

FRENCH STUDY

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	UPPER ENDOSCOPY	UPPER ENDOSCOPY

Timeline

Start date: 2011-03-01
Primary completion: 2011-03-01
Completion: 2015-12-31
First posted: 2020-01-13
Last updated: 2020-01-13

Source: ClinicalTrials.gov record NCT04224896. Inclusion in this directory is not an endorsement.